Citigroup
SKIN icon

Citigroup’s SkinHealth Systems SKIN Stock Holding History

Citigroup’s Portfolio SKIN Stock Details SKIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Sell
1
-36,417
-100% -$27.8K ﹤0.01% 5665
2026
Q1 		$32.4K Buy
36,418
+33,831
+1,308% +$41.5K ﹤0.01% 4676
2025
Q4 		$3.6K Sell
2,587
-2,101
-45% -$3.04K ﹤0.01% 5341
2025
Q3 		$9.33K Sell
4,688
-35,730
-88% -$72.5K ﹤0.01% 5045
2025
Q2 		$77.2K Sell
40,418
-12,639
-24% -$17.8K ﹤0.01% 4544
2025
Q1 		$71.1K Sell
53,057
-6,841
-11% -$10.4K ﹤0.01% 4770
2024
Q4 		$95.2K Buy
59,898
+6,204
+12% +$9.75K ﹤0.01% 4862
2024
Q3 		$77.3K Buy
53,694
+16,384
+44% +$26.9K ﹤0.01% 4878
2024
Q2 		$71.6K Buy
37,310
+23,866
+178% +$67.2K ﹤0.01% 4382
2024
Q1 		$59.7K Sell
13,444
-34,786
-72% -$113K ﹤0.01% 4539
2023
Q4 		$150K Buy
48,230
+14,725
+44% +$55.3K ﹤0.01% 4046
2023
Q3 		$202K Sell
33,505
-102,847
-75% -$722K ﹤0.01% 3657
2023
Q2 		$1.14M Sell
136,352
-52,296
-28% -$543K ﹤0.01% 2748
2023
Q1 		$2.38M Sell
188,648
-17,016
-8% -$197K ﹤0.01% 1903
2022
Q4 		$1.87M Buy
205,664
+43,542
+27% +$470K ﹤0.01% 2093
2022
Q3 		$1.91M Sell
162,122
-35,086
-18% -$444K ﹤0.01% 2175
2022
Q2 		$2.54M Buy
197,208
+51,916
+36% +$696K ﹤0.01% 1943
2022
Q1 		$2.45M Buy
145,292
+18,985
+15% +$313K ﹤0.01% 2197
2021
Q4 		$3.05M Buy
126,307
+28,523
+29% +$735K ﹤0.01% 2247
2021
Q3 		$2.54M Buy
97,784
+48,630
+99% +$1.07M ﹤0.01% 2341
2021
Q2 		$826K Buy
49,154
+22,243
+83% +$304K ﹤0.01% 3368
2021
Q1 		$290K Buy
+26,911
New +$296K ﹤0.01% 3813

Other funds holding SKIN

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.1B AUM 20.71% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Citigroup's SKIN Position: Q2 2026 in Review

Citigroup reduced its SkinHealth Systems (SKIN) stake by 100% in Q2 2026, selling an estimated $27.8K and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5665.

Citigroup first reported a position in SKIN in Q1 2021 and has held it in 22 quarters since. The position peaked at $3.05M in Q4 2021. 96 funds tracked by Wall St. Rank hold SKIN as of Q2 2026.

  • Citigroup held 1 share of SkinHealth Systems worth $1 as of Q2 2026.
  • Citigroup sold 36,417 SkinHealth Systems shares in Q2 2026, an estimated $27.8K.
  • SkinHealth Systems made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5665 holding.
  • Citigroup first reported a position in SkinHealth Systems in Q1 2021 and has held it in 22 quarters since.
  • Citigroup's SkinHealth Systems position peaked at $3.05M in Q4 2021.
  • 96 funds tracked by Wall St. Rank held SkinHealth Systems as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.